Trazodone is not an effective treatment for panic attacks. In the most direct clinical trial comparing it to established panic disorder treatments, only 2 out of 17 patients who completed at least four weeks on trazodone were considered good or complete responders. The drug was also poorly tolerated by panic disorder patients in that study. While trazodone does have some anxiety-reducing properties, its role in managing acute panic is limited, and it is not FDA-approved for panic disorder.
What Trazodone Is Approved For
Trazodone is FDA-approved solely for treating major depressive disorder in adults. It is commonly prescribed off-label for insomnia because of its strong sedating effects, and sometimes for generalized anxiety. But “anxiety” and “panic attacks” are not the same thing, and a medication that helps with one does not necessarily help with the other. Panic disorder involves sudden, intense surges of fear with physical symptoms like racing heart, chest tightness, and shortness of breath. These episodes require treatments with a specific evidence base.
Why It Falls Short for Panic Disorder
In a double-blind clinical trial comparing trazodone to imipramine (a tricyclic antidepressant) and alprazolam (a benzodiazepine), trazodone performed poorly. Most patients on trazodone dropped out before completing four weeks, and the drug was considered ineffective relative to both comparators. This is a significant finding because it tested trazodone head-to-head against medications with proven track records for panic.
The problem likely comes down to how trazodone works in the brain. It blocks serotonin reuptake (similar to SSRIs) while also blocking specific serotonin receptors called 5-HT2A and 5-HT2C. This dual action makes it useful for depression and general anxiety because blocking those receptors can reduce restlessness and improve sleep. But panic disorder involves a different neurological cascade, one that responds better to medications that more broadly stabilize the brain’s fear circuitry over time, like SSRIs, or that rapidly calm the nervous system, like benzodiazepines.
Where Trazodone Does Help With Anxiety
Trazodone has shown real benefits for generalized anxiety, the kind characterized by persistent, hard-to-control worry rather than sudden panic episodes. In one trial, it performed comparably to both imipramine and diazepam for generalized anxiety disorder. Some studies have also found that trazodone can reduce anxiety symptoms within the first week of treatment, faster than certain SSRIs like sertraline when measured on standard anxiety rating scales.
An extended-release form of trazodone has also shown improvements in anxiety and depression dimensions of quality-of-life measures that were superior to SSRIs in at least one study. Patients on the extended-release formulation reported greater improvements in daily activities, pain, and overall well-being compared to those taking SSRIs. These results, however, were measured in people with major depression, not panic disorder specifically.
The typical starting dose for anxiety is 75 mg daily, according to NHS prescribing guidance, with the possibility of increasing up to 300 mg depending on response. This is a daily maintenance medication. It takes at least two weeks to reach full effect, which means it cannot stop a panic attack that is happening right now.
It Won’t Stop an Active Panic Attack
One of the most important things to understand is that trazodone is not an as-needed medication for acute panic. It must be taken consistently, typically twice daily with food, to build up in your system. Even for depression, patients are told it may take two weeks or longer to feel the full benefit. If you are looking for something to take during a panic attack to bring symptoms down quickly, trazodone is not designed for that role. Fast-acting options like benzodiazepines work within minutes, while trazodone’s sedating effects, though noticeable early on, do not target the specific mechanisms driving a panic episode.
Side Effects Worth Knowing About
Trazodone’s sedation is its most prominent side effect, which is why it is so widely used for sleep. For someone with panic disorder, heavy drowsiness during the day can be counterproductive. The drug also blocks certain adrenaline receptors, which can cause dizziness or lightheadedness when standing up quickly. For someone already dealing with the physical symptoms of panic, these effects can feel unsettling.
A more serious concern is serotonin syndrome, a rare but dangerous reaction that can occur when trazodone is combined with other medications that raise serotonin levels. This includes other antidepressants, certain pain medications (particularly fentanyl and meperidine), migraine drugs, and even some supplements. Symptoms include agitation, rapid heartbeat, high body temperature, and muscle twitching. If you are taking trazodone alongside any other serotonin-affecting medication, this interaction is important to be aware of.
What Works Better for Panic Attacks
First-line treatments for panic disorder are SSRIs like sertraline and paroxetine, along with a type of older antidepressant called SNRIs. These medications, taken daily, reduce the frequency and severity of panic attacks over several weeks. Cognitive behavioral therapy, particularly a form that includes gradual exposure to feared sensations, is equally effective and often used alongside medication.
For stopping a panic attack in progress, benzodiazepines remain the most reliable option, though they carry risks of dependence with regular use and are generally recommended as a short-term bridge while longer-acting treatments take effect. Some people also benefit from breathing techniques and grounding exercises during an episode, though these are skills that typically need to be practiced in advance to be effective under stress.
If you are currently taking trazodone for depression or insomnia and also experiencing panic attacks, the trazodone may help with your overall mood and sleep quality without addressing the panic directly. Treating panic disorder usually requires adding or switching to a medication with stronger evidence for that specific condition.